Search results
Showing 1651 to 1665 of 8938 results
Evidence-based recommendations on atezolizumab (Tecentriq) with nab-paclitaxel for triple-negative, unresectable, PD-L1-positive, locally advanced or metastatic breast cancer in adults who have not had chemotherapy for metastatic disease.
Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)
Evidence-based recommendations on burosumab (Crysvita) for X-linked hypophosphataemia in children and young people.
Evidence-based recommendations on tucatinib (TUKYSA) for HER2-positive locally advanced or metastatic breast cancer in adults after 2 or more anti-HER2 treatment therapies.
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency (HST26)
Evidence-based recommendations on eladocagene exuparvovec (Upstaza) for treating aromatic L-amino acid decarboxylase deficiency in people 18 months and over.
In development Reference number: GID-NG10443 Expected publication date: 25 March 2026
In development Reference number: GID-IPG10404 Expected publication date: 25 March 2026
Surgical insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock
In development Reference number: GID-IPG10461 Expected publication date: 25 March 2026
In development Reference number: GID-IPG10318 Expected publication date: 25 March 2026
Topic prioritisation
Topic prioritisation
High Definition – transcranial Electrical Stimulation (HD-tES) for fibromyalgia
Topic prioritisation
Topic prioritisation
Low-level laser therapy (photobiomodulation) for oral neuropathic pain
Topic prioritisation